Analysis of Risk Factors for Central Venous Catheter-Related Complications A Prospective Observational Study in Pediatric Patients With Bone Sarcomas

被引:8
作者
Abate, Massimo Eraldo [1 ]
Escobosa Sanchez, Olga [4 ]
Boschi, Rita [1 ]
Raspanti, Cinzia [1 ]
Loro, Loretta [2 ]
Affinito, Domenico [3 ]
Cesari, Marilena [1 ]
Paioli, Anna [1 ]
Palmerini, Emanuela [1 ]
Ferrari, Stefano [1 ]
机构
[1] Ist Ortoped Rizzoli, Dept Chemotherapy, I-40136 Bologna, Italy
[2] Ist Ortoped Rizzoli, Radiol Sect, I-40136 Bologna, Italy
[3] Ist Ortoped Rizzoli, Ultrasound Sect, I-40136 Bologna, Italy
[4] Carlos Haya Hosp, Pediat Oncol Unit, Malaga, Spain
关键词
Catheter-related infections; Pediatric oncology; Sarcoma; Thrombosis; HIGH-DOSE METHOTREXATE; ANTITHROMBOTIC THERAPY; NEOADJUVANT CHEMOTHERAPY; CANCER-PATIENTS; YOUNG-ADULTS; CHILDREN; THROMBOEMBOLISM; PREVENTION; GUIDELINES; THROMBOSIS;
D O I
10.1097/NCC.0b013e31829627e7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of central venous catheter (CVC)-related complications reported in pediatric sarcoma patients is not established as reports in available literature are limited. The analysis of risk factors is part of the strategy to reduce the incidence of CVC complications. Objective: The objective of this study was to determine the incidence of CVC complications in children with bone sarcomas and if defined clinical variables represent a risk factor. Methods: During an 8-year period, 155 pediatric patients with bone sarcomas were prospectively followed up for CVC complications. Incidence and correlation with clinical features including gender, age, body mass index, histology, disease stage, and use of thromboprophylaxis with low-molecular-weight heparin were analyzed. Results: Thirty-three CVC complications were recorded among 42 687 CVC-days (0.77 per 1000 CVC-days). No correlation between the specific clinical variables and the CVC complications was found. A high incidence of CVC-related sepsis secondary to gram-negative bacteria was observed. Conclusions: The analysis of CVC complications and their potential risk factors in this sizable and relatively homogeneous pediatric population with bone sarcomas has led to the implementation of a multimodal approach by doctors and nurses to reduce the incidence and morbidity of the CVC-related infections, particularly those related to gram-negative bacteria. Implications for Practice: As a result of this joint medical and nursing study, a multimodal approach that included equipping faucets with water filters, the reeducation of doctors and nurses, and the systematic review of CVC protocol was implemented.
引用
收藏
页码:292 / 298
页数:7
相关论文
共 33 条
[1]   Guidelines for antithrombotic therapy in pediatric patients [J].
Andrew, M ;
Michelson, AD ;
Bovill, E ;
Leaker, M ;
Massicotte, MP .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :575-588
[2]   Epidemiology and Clinical Risk Factors Predisposing to Thromboembolism in Children With Cancer [J].
Athale, Uma ;
Siciliano, Sabrina ;
Thabane, Lehana ;
Pai, Nikhil ;
Cox, Stephanie ;
Lathia, Anita ;
Khan, Anees ;
Armstrong, Ankelly ;
Chan, Anthony K. C. .
PEDIATRIC BLOOD & CANCER, 2008, 51 (06) :792-797
[3]   Thromboembolism in children with sarcoma [J].
Athale, Uma ;
Cox, Stephanie ;
Siciliano, Sabrina ;
Chan, Anthony K. C. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (02) :171-176
[4]   Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute [J].
Bacci, G ;
Mercuri, M ;
Longhi, A ;
Bertoni, F ;
Barbieri, E ;
Donati, D ;
Giacomini, S ;
Bacchini, P ;
Pignotti, E ;
Forni, C ;
Ferrari, S .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) :2243-2251
[5]   High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: Preliminary results of an Italian sarcoma group/Scandinavian sarcoma group pilot study [J].
Bacci, G ;
Ferrari, S ;
Longhi, A ;
Picci, P ;
Mercuri, M ;
Alvegard, TA ;
Saeter, G ;
Donati, D ;
Manfrini, M ;
Lari, S ;
Briccoli, A ;
Forni, C .
JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) :198-206
[6]   Prospective, Randomized Trial of Two Different Modalities of Flushing Central Venous Catheters in Pediatric Patients With Cancer [J].
Cesaro, Simone ;
Tridello, Gloria ;
Cavaliere, Mara ;
Magagna, Laura ;
Gavin, Patrizia ;
Cusinato, Riccardo ;
Zadra, Nicola ;
Zanon, Giovanni Franco ;
Zanesco, Luigi ;
Carli, Modesto .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2059-2065
[7]   Primary thromboprophylaxis for cancer patients with central venous catheters - a reappraisal of the evidence [J].
Cunningham, MS ;
White, B ;
Hollywood, D ;
O'Donnell, J .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :189-194
[8]   Central venous catheter-related septicaemia in paediatric cancer patients [J].
Das, I ;
Philpott, C ;
George, RH .
JOURNAL OF HOSPITAL INFECTION, 1997, 36 (01) :67-76
[9]   Clinical management of catheter-related infections [J].
Fätkenheuer, G ;
Cornely, O ;
Seifert, H .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (09) :545-550
[10]   Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups [J].
Ferrari, S ;
Smeland, S ;
Mercuri, M ;
Bertoni, F ;
Longhi, A ;
Ruggieri, P ;
Alvegard, TA ;
Picci, P ;
Capanna, R ;
Bernini, G ;
Müller, C ;
Tienghi, A ;
Wiebe, T ;
Comandone, A ;
Böhling, T ;
Del Prever, AB ;
Brosjö, O ;
Bacci, G ;
Sæter, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8845-8852